Paula Wilson

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · The Lancet · 2016 · 710 citations · Full text

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

Amelia Clive, Hazel Taylor, Lee Dobson et al. · The Lancet Oncology · 2016 · 164 citations · Full text

Potential for Higher Treatment Failure in Obese Patients: Correlation of Elevated Body Mass Index and Increased Daily Prostate Deviations From the Radiation Beam Isocenters in an Analysis of 1,465 Computed Tomographic Images

James R. Wong, Zhanrong Gao, S. Merrick et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 72 citations

Obesity, Urology, Body Composition +13

A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer

Peter Hoskin, Santhanam Sundar, Krystyna Reczko et al. · JNCI Journal of the National Cancer Institute · 2015 · 43 citations · Full text

Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).

P. Mulvenna, Matthew Nankivell, Rachael Barton et al. · Journal of Clinical Oncology · 2015 · 29 citations